Skip to main content

Arexvy News (Page 2)

Education on Approval Process May Increase Acceptance of New RSV Vaccines

MONDAY, Aug. 14, 2023 – People are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from respiratory syncytial virus (RSV) if they are shown...

FDA Approves Arexvy (respiratory syncytial virus vaccine, adjuvanted) Respiratory Syncytial Virus (RSV) Vaccine for Older Adults

May 3, 2023 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Arexvy patient information at Drugs.com